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Abstract  
The vast majority of cancer cases worldwide are diagnosed in low- and middle-income 
countries (LMICs) each year. However, much of our knowledge about cancer is produced in 
the United States and Europe. This is in spite of a growing number of collaborative 
initiatives in oncology between institutions in the West and their counterparts in LMICs. In 
the same manner as global health, global oncology adopts notions of pluralism and equity. 
However, countries with limited resources that are unable to attend to their own health 
problems exhibit characteristics of academic dependency, which include a reliance on 
Western research agendas and priorities. Postcolonial countries are particularly susceptible to 
academic dependency due to a number of factors such as language barriers, a sense of 
intellectual inferiority, persistent orientalist stereotypes, and the ‘exoticization’ of locally 
produced knowledge. Additionally, the ability to conduct independent research is severely 
impeded by the undemocratic priorities of postcolonial governments. 
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Introduction 
Prior to the 1960s, the care of patients diagnosed with cancer was the domain of internal 
medicine, surgery, and radiation therapy. It was not until chemotherapy emerged as a valid 
therapeutic option through clinical trial testing that medical oncology as a distinct discipline 
was born (Krishnan 2009). Since then, shifting discourses and competing interests, not least 
those brought about by commodification of science, have continuously redefined the field of 
cancer medicine (de Oliveira 2013).  
Despite fierce institutional opposition, oncology was quickly isolated from other medical 
specialties with the establishment of dedicated cancer centers (Nathan and Benz 2001). In 
1969, Tunisia and Egypt were among the first countries worldwide to create comprehensive 
cancer centers that provide cancer care and research across a wide array of 
subspecializations. 
Yet, despite being early adopters of the new discipline and although an estimated two-thirds 
of cancer cases worldwide each year are diagnosed in low-income countries (Hayes 2017), 
much of our knowledge about cancer is produced in the United States and Europe (Paraje, 
Sadana, and Karam 2005). This is in spite of an expanding number of collaborative initiatives 
across the field between institutions in the West and their counterparts in postcolonial 
countries. 
As a medical oncologist at the National Cancer Institute in Egypt and an adjunct assistant 
professor at the University of Texas, MD Anderson Cancer Center, I participate in 
multicenter international cancer research collaborations. In addition, my role as an official 
coordinator for Egypt involves working in close cooperation with the Global Academic 
Program at MD Anderson to develop and encourage collaborations in oncology between the 
two institutions. I also serve on the editorial board of the Journal of Global Oncology, published 
by the American Society of Clinical Oncology. My aim in this article is to reflect on the 
dynamics of scientific collaboration in the relatively new field of cancer medicine with a 
special focus on a specific type of collaboration between institutions in the West and their 
counterparts in postcolonial countries. Although I use examples from my own experience in 
Egypt, the discussion presented here applies more broadly to the challenges facing 
postcolonial countries that participate in global oncology collaborations. In particular, I 
would like to focus on the elements that prevent postcolonial countries from breaking a 
cycle of academic dependency. Among the characteristics of academic dependency is the 
inability to initiate and conduct science at a global level, a reliance on foreign aid, and a 
dependence on Western research agendas and priorities (Alatas 2003).  
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This postcolonial critique of global health collaborations traces the cultural legacy of 
colonialism by examining issues of power, politics, economics, and language and how they 
continue to hinder the success of these collaborations. I argue that oncology functions as a 
scientific discipline and therefore retains the capability to ‘characterize, classify, specialize; 
distribute along a scale, around a norm, hierarchize individuals in relation to one another 
and, if necessary, disqualify and invalidate’ (Foucault 1977, 223). 
Beyond independence 
Egypt was at the heart of the postcolonial struggle and played a key leadership role in the 
founding of the nonaligned movement (Tignor 2011). Although Egypt was the first country 
in Africa to achieve formal independence in 1922, it wasn’t until 1956 that it was able to 
break free from British occupation. When in July of that year, President Gamal Abdel 
Nasser, frustrated by the American refusal to fund his Aswan Dam project, announced the 
nationalization of the Suez Canal, the armies of Britain, France, and Israel invaded Egypt 
with the aim of restoring ownership of the canal that had been described as the ‘lifeblood of 
the Empire’ (Louis 1984). Under immense international pressure the invading armies were 
forced to back down, marking an end to British and French colonial influence and hastening 
the process of decolonization throughout the world (Smith 2016). 
Domestically, Nasser’s Arab socialist economic policies, which became known as Nasserism, 
continued to fund ambitious national projects such as Egypt’s public health system, 
including the Egyptian National Cancer Institute (Hassouna and Abou Ali 1996). 
Intriguingly, after Nasser’s death, the Egyptian National Cancer Institute was selected to 
become the first project to benefit from the newly released US aid, which had previously 
been denied to Nasser and sparked the Suez crisis (Hoogstraten 2005). The emergence of 
scientific collaboration from the center of the postcolonial struggle is demonstrative of the 
overlap between power, politics, and knowledge production. 
Dr. Barth Hoogstraten (2005), the founding chairman of one of the earliest clinical trial 
collaborative groups in the United States, the South West Oncology Group (SWOG), 
describes in his memoir how he was summoned by the US State Department to approve 
Egypt’s application to join his group. Egypt’s membership would allow the newly formed 
cancer institute to contribute to cutting-edge cancer research by offering participating 
oncologists the opportunity to enroll Egyptian patients in SWOG trials.  
Hoogstraten’s account offers a rare insight into his encounters with his Egyptian 
counterparts and the US ambassador. ‘If I approve the request, I must make one thing 
perfectly clear. I’ll decide who will attend the SWOG meetings’, he informed the dean of the 
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Egyptian National Cancer Institute, Dr. Mohamed El-Sebai (Hoogstraten 2005, 138). 
Subsequently, after SWOG accepted Egypt as a new member, a newly appointed Egyptian 
dean changed the list of participants, but Hoogstraten stood his ground. Later, when the US 
ambassador tried to intervene on behalf of the Egyptian side, there was a standoff: ‘Doctor, 
you are interfering with State Department business’, warned the ambassador, ‘And you, Mr. 
Ambassador, are interfering with SWOG business’, Hoogstraten responded. Hoogstraten 
goes on to acknowledge that he had to lie to the US ambassador to get his way (Hoogstraten 
2005, 138). 
Global initiatives 
Science was not always collaborative. Most of the early modern scientific discoveries in 
physics and chemistry were the works of single authors or institutions. The disciplining of 
knowledge and the subsequent institutionalization and systematization of the various 
academic fields was followed by the emergence of collaborative research. For the purpose of 
this article, I use the term ‘scientific collaboration’ to refer to a commitment between 
members of discrete research institutions to share resources towards any number of identical 
objectives that result in the production of knowledge (Thistlethwaite, Jackson, and Moran 
2013). These collaborations may form part of broader institution-wide partnerships or co-
operative ventures that are centered around an ‘intersection of common goals’ (Marinez-
Moyano 2006). In oncology, the establishment of clinical trial cooperative groups such as 
SWOG was commissioned by the US National Cancer Institute and the European Union 
and has been fundamental in providing large-scale clinical trial data. 
More recently, however, there has been an upsurge in collaborations initiated by influential 
institutions in the West that seek opportunities with ‘global partners’ (Crane 2013). The 
objectives and dynamics of global collaborations differ from the more traditional forms of 
collaboration, in that there is often an awareness of inequality by both parties. Conscious of 
this inequality and the historical lack of trust towards Western health initiatives (Tilley 2016), 
global health has been careful to espouse notions of equality and inclusion (Koplan et al. 
2009). However, despite insistence that that the term ‘global’ refers to scope and not 
location, the vast majority of global health initiatives are headed by Western universities 
(Merson and Page 2009). As such, the ability to initiate and conduct science at a global level 
is a manifestation of dominance. For countries with limited resources that are unable to 
attend to their own health problems, participation in global collaborations puts them on the 
receiving end and these participants cannot be considered engaged in science at a global 
scope. 
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Oncology has been slow to jump on the ‘Global Health’ bandwagon, which continues to be 
dominated by infectious diseases and maternal and child health (Koplan et al. 2009; Fouad 
2014). Global collaborations in oncology have been spearheaded by a number of influential 
cancer centers and national programs in the United States and have adopted similar notions 
of pluralism and equity (Mika 2016). In the same manner as global health, global oncology 
links enlightened self-interest with an altruistic call to integrate ‘developing countries’ into 
the expansive global network of information and commodity exchange (King 2002). 
However, in doing so, global oncology perpetuates a universalized discipline and presents its 
approach, taxonomy, priorities, and means of knowledge production and distribution as the 
only way to conduct cancer medicine.  
The postcolonial dimension 
European colonialism has had a destructive and lasting legacy on many of its former 
colonies. The exploitation and subordination of the colonies was to subsequently render 
them dependent on the metropole. Upon gaining independence, many of these countries 
undertook a path towards ‘modernization’, which for the most part was synonymous with 
Europeanization or Westernization (Chew and Lauderdale 2010). 
In the context of scientific collaborations, the modernization narrative perpetuates a model 
in which scientific knowledge spreads by linear diffusion from the West, which resides at an 
imaginary center while all others reside in the periphery (Von Gizycki 1973). Ultimately the 
modernization narrative has the effect of shifting the responsibility for successful 
‘development’ onto the postcolonial subject rather than addressing structural challenges, 
such as unfair terms of cooperation and technological transformations in the means of 
production (Sumberg, Mader, and Flynn 2016).  
Moreover, the pervasive force of colonial ideology resulted in colonial subjects that had 
internalized the belief in an inherent Western intellectual superiority, and, in turn, their own 
inferiority. This phenomenon persists in postcolonial countries under a variety of terms, 
such as ‘colonial mentality’, or ‘ةجاوخلا ةدقع’, which translates into ‘the foreigner complex’ or 
‘cultural inferiority complex’, and describes a conviction that anything Western is good and 
anything local is bad. This is recognized as having palpable economic and political 
ramifications, and no doubt scientific ones. On the other hand, Orientalist stereotypes 
remain prevalent in the West and continue to influence perceptions of competence, 
transparency, and data accuracy of many postcolonial scientists.  
Today in many parts of Africa, the language in which oncology is taught and practiced is 
communicated along colonial lines despite the establishment of English as the universal 
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language of science (van Weijen 2012). This entails additional effort on the part of scientists 
who come from Francophone countries for example, should they wish to publish globally 
recognized work. But even for fluent English speakers from postcolonial countries, the 
playing field is far from level (see also Boum this issue). For knowledge produced in 
postcolonial countries to be published in influential journals it must contribute to Western 
research agendas, Western problem areas, and reflect Western standards of excellence. On 
the other hand, if the knowledge produced does not meet Western demands it is not denied 
but frequently ‘exoticized’, isolated and presented as relevant only within its own 
geographical and cultural setting (Lillis and Curry 2010, 141). This would explain in part the 
recent trend in English-language ‘global’ offshoots of renowned oncology journals. 
Ultimately, the most damaging effect of this is that the science performed in postcolonial 
countries takes its cues from the West rather than addressing local priorities. For example, 
rather than being grounded in local objectives, a large proportion of published doctoral 
dissertations in Egypt employ scientific mimicry, a detrimental process, whereby novel 
scientific discoveries published in the West are ‘localized’ or confirmed with local patients. 
In most cases, these studies will bear very little impact on local clinical practice. 
A postcolonial analysis is also concerned with the political and economic collapse in newly 
independent states, and the rise of postcolonial dictatorships and the tacit support they 
receive from the West in view of shared financial and political interests (Nkrumah 1968). For 
the postcolonial scientist, science doesn’t occur in a vacuum and is often performed within a 
political environment that prioritizes political loyalty over competence. This greatly impedes 
capacity building in postcolonial countries by making it more difficult for budding scientists 
to pursue successful careers based on merit or effort alone. Moreover, institutional 
leadership appointments that are based on loyalty can be detrimental to the quality of 
research produced. Perhaps a dramatic example of this incompetence occurred in Egypt 
recently, with the publicized announcement of the breakthrough development of what was 
dubbed a ‘Complete Cure Device’, that cured both viral hepatitis C and HIV, much to the 
shock of the local scientific community (Abdelaziz and Abedine 2014). The press conference 
was led by Major General Ibrahim Abdel-Atti, who had been appointed as head of the 
Cancer Treatment and Screening Center, and was subsequently found to be wholly 
unqualified for his position. 
In addition, ill-informed concerns about national security directly impede scientific discovery 
and data sharing in some postcolonial countries, while the conduct of first-in-human (phase 
I) clinical trials are prohibited in others (Public Eye et al. 2016). In Egypt, where half of the 
international drug trials are cancer related, sending tissue or blood samples abroad requires 
obtaining approvals from several agencies including Egypt’s homeland security agency. This 
incurs significant delays and adversely affects the participation of Egyptian researchers in 
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international trials that require evaluation by a central laboratory or when advanced 
laboratory equipment is not available in Egypt. Moreover, international research funds are 
closely monitored by security agencies, and the activities of nongovernmental research 
organizations are severely restricted. 
Science as an endless frontier 
Rather than viewing the production of knowledge as simply a benevolent exercise in the 
pursuit of truth, French philosopher Michel Foucault linked knowledge production to 
disciplinary power within a given epoch. In his view, power was a producer of reality, not 
merely a means of repression, censorship, or exclusion (Foucault 1977).  
Foucault also criticized the linear model of scientific accumulation and instead saw science as 
emanating from various discursive formations that exist as a historical a priori and ‘defines 
the conditions of possibility for all knowledge’ within a particular epoch. He referred to 
these discursive preconditions as ‘épistèmes’ or, as he explains, ‘the épistème is the 
“apparatus”, which makes possible the separation, not of the true from the false, but of what 
may from what may not be characterized as scientific’ (Foucault 1980, 197). Several épistèmes 
that stem from different power/knowledge systems may coexist and interact at the same 
time. 
By approaching science from a critical perspective, we are able to trace a variety of épistèmes 
that are relevant to understanding the power dynamics within global oncology collaborations 
today. In the wake of the Second World War, the perception that the Allied victory was 
linked to the technological superiority of US military has had a persisting legacy in shaping 
American commitment to scientific research. Vannevar Bush, who was in charge of US 
military research and development during the war, proposed a state of perpetual 
mobilization of American society in the pursuit of scientific superiority and dictated the 
enduring terms between science, the government, and the military (Zachary 1999). In his 
report to President Truman, ‘Science, the Endless Frontier’, Bush laid the blueprint for the 
large-scale government funding of university-based research which is directly responsible for 
the leadership status in cancer research that the United States enjoys today (Walter, 
Saunders, and Putney 1985, Walter and King 1977, Institute of Medicine National Academy 
of Sciences 1989). President Nixon’s National Cancer Act of 1971 laid the groundwork for 
the creation of more than sixty designated cancer centers across the United States under the 
National Cancer Institute’s Cancer Centre Program (National Cancer Institute 2015). 
Currently, many of these cancer centers have budgets larger than the budgets of entire 
governments in Africa, making collaborations with corresponding cancer centers in low-
income countries incongruous from the start (NEPAD 2006). 
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The subsequent shift in the dominant economic model in the United States towards 
neoliberalism in the 1970s, with its promotion of privatization, deregulation, and free market 
economics, has steered science towards ‘innovationism’. This marks a significant departure 
from Bush’s emphasis on government patronage of science and has raised concerns among 
the scientific community (Ronald 2014). Market-driven innovationism restricts scientific 
enquiry to commercially viable discoveries with a particular emphasis on product novelty (de 
Oliveira 2013). Market-driven novelty is ingrained into the product life cycle and is essential 
for the developer to enjoy a patent-protected market monopoly (United States Patent and 
Trademark Office 2013). By linking science to profitability, innovation thrives in the more 
lucrative markets of the United States, Europe, and Japan, and is not a viable model to 
address the health priorities of less affluent countries. 
Neoliberalism has been a powerful driver of globalization (Litonjua 2008), and has informed 
many of the discursive foundations of global health. In oncology, the growing alliance 
between industry and academia has been transformative. The emergence of translational 
research drove laboratory research towards clinically applicable, and ultimately 
‘commercializable’, objectives rather than the unrestricted exploration of the mechanistic 
aspects of disease (Cambrosio et al. 2006; Goldstein and Brown 2012; Jogalekar 2012). In 
the rapidly changing field, cancer researchers from less affluent countries are finding it 
difficult to keep up with the rapid technological transformations in the means of knowledge 
production. As a result, collaborators from these countries are increasingly finding 
themselves relegated to the role of providing samples or testing new drugs in a global 
division of labor that produces science that will not benefit patients locally (Public Eye et al. 
2016). 
Regimes of truth 
Oncology as a discipline universalizes a positivist approach to medicine that follows a 
standardized approach to clinical practice, is communicated in English, and is published in 
Western journals. It is on these terms that partnerships are made. 
The universalization of evidence-based medicine (EBM) is a particularly critical point for 
global oncology that warrants careful consideration. EBM is a standardized approach that 
links the practice of medicine to ‘state of the art’ empirical knowledge. More subtly it links 
clinical practice to the production of knowledge. In other words, oncologists in low-income 
countries who are unable to treat patients according to guidelines in the West often find 
themselves with data that is neither comparable to the scientific cannon nor publishable. In 
global collaborations between cancer institutions in low-income countries and those in the 
West, differences in treatment often lead to significant differences in patient survival and 
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make the analysis of pooled data extremely complicated. As a result, the postcolonial 
oncologist finds herself alienated from both the production of knowledge and the product of 
her labor. The science discussed at conferences, presented at grand rounds, and read in 
journals bears a diminishing impact on daily practice (Livingston 2012; Feierman 2011).  
In addition, EBM is associated with the creation of a new type of intellectual, the Principal 
Investigator, who is a member of a clinical trial network, carries out clinical research, 
presents results at international conferences, and publishes scientific evidence that produces 
standardized clinical consensus guidelines. In this sense, EBM also determines which 
research questions can be asked, by whom, and who can speak for medicine. 
Although research institutions in LMICs participate in global health collaborations with the 
goal of improving capacity and building a sustainable research infrastructure, in most cases 
the delivery of these objectives are not formulated in the collaboration proposal. As a result, 
global collaborations are mainly concerned with achieving short-term project objectives as 
completely and as efficiently as possible. This is far from easy in a low-capacity, low-
technology setting and in many cases is overcome by ‘quick fixes’ that may be detrimental to 
the long-term goals of less affluent countries. For example, Crane (2011) describes how US 
universities establish parallel administrative systems in host countries in the form of shell 
nongovernmental organizations in order to bypass the tenacious institutional bureaucracy in 
African universities. This approach undermines capacity building by taking the easy route 
rather than partnering with African universities to rebuild their administrative infrastructure.  
The rapid technological transformations in the West are challenging the status of oncology 
as a universalized discipline. Standardized treatment guidelines in the West are becoming less 
applicable in low-income settings. Similarly, the anatomical gaze in oncology is being 
replaced by a molecular gaze and changing the way that cancer is classified (Amin et al. 
2017). The recent regulatory approval of the tumor site agnostic indication for the immune 
drug pembrolizumab is a case in point (U.S. Food and Drug Administration 2017). 
Traditionally, cancer is classified, and as a result, treated, based on its tissue of origin (for 
example, breast cancer, skin cancer, etc.). Tissue-agnostic drugs are a new class of cancer 
drugs that are used to treat cancer based on the presence of a molecular biomarker 
regardless of the tissue affected. Similarly, the upcoming edition of the American Joint 
Committee on Cancer staging manual, which is the standard cancer staging system 
worldwide, introduces a two-tier staging system in order to incorporate the use of advanced 
molecular biomarkers, which are not available in most parts of the world (Giuliano et al. 
2017).  
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Conclusion  
In this article, I have sought to expose some of the power dynamics and conflicting interests 
at the root of academic dependency in global collaborations in the rapidly changing field of 
oncology. This has created a global division of labor whereby many collaborators from 
LMICs are relegated to the role of providing samples rather than contributing to the design 
and conduct of scientific projects. Postcolonial researchers face additional challenges in the 
form of language barriers, a sense of intellectual inferiority, persistent orientalist stereotypes, 
and the ‘exoticization’ of locally produced knowledge. More importantly, the ability to 
conduct independent research is severely impeded by the political priorities of undemocratic 
postcolonial governments that maintain close financial and political ties with the West. 
Global oncology perpetuates a universalized discipline by integrating ‘developing countries’ 
into the global network of information and commodity exchange while maintaining control 
of the means of knowledge production and knowledge distribution. Moreover, the rapid 
technological transformations in the West are changing the way oncology is practiced and 
the way tumors are classified making it difficult for oncologists in non-Western countries to 
contribute equally to cancer research.  
It is important that scientists in the West acknowledge these inequalities to avoid 
overlooking the interests of postcolonial researchers, which should drive collaborations with 
Western institutions. Rather than adopt scientific programs that are based on modernization, 
governments in postcolonial countries should focus on the creation of a system that insists 
on the applicability of research findings to local objectives. This system would encompass 
the local production, control, and delivery of knowledge and leverage local capacities with 
scientific programs that are driven by local priorities. 
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